Explore Cancer Immunotherapy, Drug Discovery, and more!

In 2020, the #Angiogenesis Inhibitor Drug Class Will Account for Nearly Half of the Ovarian #Cancer Drug Market

Roche's ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study Basel, 28 September 2015 Phase III study meets.

NEWS: A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy, according to a new study.

NEWS: A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy, according to a new study.

Age-related macular degeneration (AMD) remained the most common cause of severe visual impairment over a 20-year period, researchers found.

AMD Remains Leading Cause of Vision Loss

The incidence of genital warts declined by more than in adolescent and teenage girls in the first 4 to 5 years after introduction of the human papillomavirus (HPV) vaccine in Australia.

New research suggests that the antioxidant vitamins found in abundance in fruits and vegetable may have a protective effect against malignant pleural mesothelioma.

New Mesothelioma Drug to Cure Cancer from Poisionous Sea Squirt A mesothelioma test created and validated at Brigham and Women/s Hospital in Boston could be available to the public within the next couple of months.

T-cell immunotherapy uses the body's own cells (L) to destroy cancer cells (R). In one study, 94 per cent of terminally ill patients saw the disease vanish completely, Seattle researchers found.

Stunning new therapy hunts down and destroys cancer cells

31 Amazing Benefits of Immunotherapy: How it Works T-cell immunotherapy uses the bodys own cells (L) to destroy cancer cells (R). In one study, 94 per cent of terminally ill patients saw the disease vanish completely, Seattle researchers found.

An immunotherapy drug is described as a potential "game changer" in promising trial results on advanced cancers.

Immunotherapy 'game changer' for cancer

cancer drug hailed as 'game changer' - BBC News: BBC News Immunotherapy cancer drug hailed as 'game changer' BBC News An…

This article talks about a new drug called Keytruda, which is being used against lung cancer.

Immunotherapy moves to the front lines in fight against lung cancer

31 Amazing Benefits of Immunotherapy: How it Works This article talks about a new drug called Keytruda, which is being used against lung cancer.

The New Frontier in Cancer Treatment: Immunotherapy as a Natural Killer Cell Therapy

Cells 21 In Revolutionary Stem Cell Therapy Program - Quebec Daily Examiner: Stem Cells 21 In Revolutionary Stem Cell Therapy Program…

F.D.A. Approves Second Gene-Altering Treatment for Cancer  ||  The treatment will be for adults with aggressive non-Hodgkin’s lymphoma when chemotherapy has failed. It re-engineers a patient’s own cells to fight cancer. https://www.nytimes.com/2017/10/18/health/immunotherapy-cancer-kite.html?emc=rss&partner=rss&utm_campaign=crowdfire&utm_content=crowdfire&utm_medium=social&utm_source=pinterest

F.D.A. Approves Second Gene-Altering Treatment for Cancer

New top story on Hacker News: F. Approves Second Gene-Altering Treatment for Cancer

The Lancet: Structural racism mass incarceration and health care system fuel growing health inequalities in the USA

The Lancet: Structural racism, mass incarceration, and health care system fuel growing health inequalities in the USA

Manipulating brain activity to boost confidence unconsciously using approaches drawn from AI to find specific patterns in the brain corresponding to high confidence states that were rewarded leading to participants being consistently more confident.

Kidney cancer

Immunotherapy 'game changer' for cancer

#Therapy #NHS NICE u-turn backs Opdivo for kidney cancer  Kidney cancer patients are now likely to get access to Bristol-Myers Sqiubb's immunotherapy on the NHS in England and Wales after all, after cost regulators had a change of heart and recommended the drug as a cost-effective treatment option. http://www.pharmatimes.com/news/nice_u-turn_backs_opdivo_for_kidney_cancer_1173169

Kidney cancer patients are now likely to get access to Bristol-Myers Sqiubb's immunotherapy on the NHS in England and Wales after all, as cost regulators have a change of heart and recommended the drug. - News - PharmaTimes

Injecting minute amounts of two immune-stimulating agents directly into solid tumors in mice can eliminate all traces of cancer in the animals, including distant, untreated metastases, according to a study by researchers at the Stanford University School of Medicine.

Injecting minute amounts of two immune-stimulating agents directly into solid tumors in mice can eliminate all traces of cancer in the animals, including distant, untreated metastases, according to a study by researchers at the Stanford University School of Medicine.

Houston’s Bellicum Pharmaceuticals Initiates Clinical Trial with Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer: http://bionews-tx.com/news/2013/07/11/bellicum-pharmaceuticals-dendritic-cell-immunotherapy-prostate-cancer/

Houston's Bellicum Pharmaceuticals Initiates Clinical Trial with Novel Controlled Dendritic Cell Immunotherapy in Metastatic Castrate Resistant Prostate Cancer

Former President Jimmy Carter on Monday won his second Grammy Award, this time for the audio book version of his memoir, "A Full Life: Reflections at Ninety."

Jimmy Carter wins Grammy Award - CNNPolitics

Former President Jimmy Carter on Monday won his second Grammy Award, this time for the audio book version of his memoir, "A Full Life: Reflections at Ninety.

Pinterest
Search